Boston Scientific Corporation (BSX) Gains 44% YTD as Farapulse Launch Drives 17% Q2 Growth
Boston Scientific Corporation (BSX) is among the top healthcare stocks to buy according to hedge funds, with strong growth potential. Its recent product launch and revenue growth have positioned it favorably in the medical device sector.